Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation.
about
Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroupsDisease rescue and increased lifespan in a model of cardiomyopathy and muscular dystrophy by combined AAV treatmentsStructural Insights into Adeno-Associated Virus Serotype 5Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb.Gene and cell-mediated therapies for muscular dystrophy.The potential of adeno-associated viral vectors for gene delivery to muscle tissue.Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size.Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer.Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vectorIntracellular transport of recombinant adeno-associated virus vectors.Recombinant adeno-associated viral vector production and purification.Recombinant adeno-associated virus vectors for gene therapy.Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advancesRecombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD).Intracellular trafficking of adeno-associated viral vectors.Biological Differences in rAAV Transduction of Airway Epithelia in Humans and in Old World Non-human Primates.Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1.Myoblast therapy: from bench to bedside.Extracorporeal delivery of rAAV with metabolic exchange and oxygenationTrans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency.Emerging strategies for cell and gene therapy of the muscular dystrophiesViral serotype and the transgene sequence influence overlapping adeno-associated viral (AAV) vector-mediated gene transfer in skeletal muscle.Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury.Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart.Targeted correction of single-base-pair mutations with adeno-associated virus vectors under nonselective conditions.A novel chimeric adenoassociated virus 2/human bocavirus 1 parvovirus vector efficiently transduces human airway epithelia.Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques.Preclinical studies for gene therapy of Duchenne muscular dystrophy.Development of Novel Recombinant AAV Vectors and Strategies for the Potential Gene Therapy of Hemophilia.Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors.Marker rescue of adeno-associated virus (AAV) capsid mutants: a novel approach for chimeric AAV production.Characterization of tissue tropism determinants of adeno-associated virus type 1.Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficiTherapeutic strategies for the inherited neuropathies.Generation and characterization of chimeric recombinant AAV vectors.Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injection.Adeno-associated virus vector-mediated transduction in the cat brain.A single adeno-associated virus (AAV)-murine factor VIII vector partially corrects the hemophilia A phenotype.Recombinant adeno-associated virus type 2 mediates highly efficient gene transfer in regenerating rat skeletal muscle.AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
P2860
Q24623923-91976F28-3DCF-45F4-A9E1-127A730275ABQ27349992-F553FBDB-55FF-4E01-AC26-D30EC007428FQ27679454-5EBF6B0F-4368-4EA4-9531-4EC0DCC21129Q33730469-78EA5440-AC39-4D44-A4F9-E45E71DB8320Q33831193-C5B8DF1C-34DE-4C09-BDB0-ED296A3E28EAQ33902499-A25CF8B3-65CD-426C-BF47-DE68A364BD23Q34342913-3FCF1D0F-8303-4DA6-A4AF-0D385F71B6D9Q34344205-3D39935D-1D58-4F44-ABA3-235C9B3CF8C5Q34348760-9D105DEB-EB47-4C5E-B8C3-CBE684A884B0Q35734826-95862E85-177C-4334-9824-978DA07555A9Q35819157-E10D87C8-C933-4EBC-8632-712FA22EFB09Q35842668-280D8E20-A4F0-4533-97AD-6FFBD98F9EA0Q35847178-E9A62A78-3889-480D-8AFF-7459EF3F7E97Q35904461-64D9287D-293D-486F-9BC3-2A7FBEA6A204Q36097743-FB71BDA2-384C-4224-B027-C2359C101082Q36238758-A48EDFB6-0351-43E1-8707-E02E5D4D9C81Q36438711-D4EB27D0-54B1-43AC-B2B5-0A293EADA2A2Q36660989-8858434B-2753-4354-9285-D73D89B8191EQ36715322-68F04F47-ED57-4F8E-A2F2-875FEED1862BQ36728106-E56D0FB1-5077-4EEC-B9EF-0C8B047E9711Q36960845-DF836113-C298-48E6-877E-2A1202400A24Q36968848-FD0BE744-9DDB-4BBF-A570-825FBE0D5C00Q36968852-88BF0E29-AFF3-4825-B6E4-C8BFE6C3A05EQ36968864-C9610CF9-6B5F-4C8C-BC67-1241E072F345Q37092798-4CDBA948-52E3-44E7-B2EF-79D31F2D5310Q37393822-9B926F3F-FE95-426A-925D-177F48623364Q37743813-864C286D-D509-4D4D-81CF-628B8FA5AFA4Q37760380-0B2AE900-FB65-48B8-8BEB-2683727960FFQ38069585-2ADA1852-1D5B-4669-A20A-EC0A9C3D23EFQ39682659-85BDF3EF-AD1A-4140-8582-A94F57D9675EQ39698557-8BC804EE-DA3C-4732-AC8A-1C6DF00C2524Q39700318-FD87D24E-3465-4044-8F24-0BA348962E38Q39756843-7CECBA8F-2691-45D9-8907-44126C986533Q40316169-D4170AA0-D573-493F-B2DF-AB6D177743E1Q41869331-08449BD0-A856-4F03-9EF9-36B638390433Q44131599-68C90A0F-5338-4C55-A429-C6052B66B9F9Q45711198-FDAC51A9-534D-42D7-8158-D577FF221084Q45722525-10C53A60-39C0-4190-9C4B-185FBE805E65Q45731861-87D54A95-85D8-4EEC-9FE9-3623BDA394D4Q45859037-7E492050-C704-4BD6-ACD7-4EE2FFAA8BE2
P2860
Enhancement of muscle gene delivery with pseudotyped adeno-associated virus type 5 correlates with myoblast differentiation.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Enhancement of muscle gene del ...... with myoblast differentiation.
@en
Enhancement of muscle gene del ...... with myoblast differentiation.
@nl
type
label
Enhancement of muscle gene del ...... with myoblast differentiation.
@en
Enhancement of muscle gene del ...... with myoblast differentiation.
@nl
prefLabel
Enhancement of muscle gene del ...... with myoblast differentiation.
@en
Enhancement of muscle gene del ...... with myoblast differentiation.
@nl
P2860
P50
P1433
P1476
Enhancement of muscle gene del ...... with myoblast differentiation
@en
P2860
P304
P356
10.1128/JVI.75.16.7662-7671.2001
P407
P577
2001-08-01T00:00:00Z